FindTrial
Sign In

A prospective randomized controlled study of high concentration iodine contrast agent combined with low radiation dose regimen for coronary CTA in obese patients

A prospective randomized controlled study of high concentration iodine contrast agent combined with low radiation dose regimen for coronary CTA in obese patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044522
Enrollment
Unknown
Registered
2021-03-23
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No specific disease

Interventions

Group 1:conventional radiation dose
Group 2:low radiation dose

Sponsors

Fuwai Hospital Chinese Academy of Medical Sciences, Shen Zhen
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Patients with known or suspected coronary heart disease should be examined by coronary CTA; (2) Aged >= 18 years; (3) BMI >= 28.

Exclusion criteria

Exclusion criteria: (1) Severe cardiac dysfunction (New York Heart Association classification IV); (2) Severe renal insufficiency (EGFR < 30ml / min); (3) History of iodine contrast allergy and other contraindications; (4) Coronary stenting; (5) Severe arrhythmia, such as atrial fibrillation; (6) Exclusion of other medical history or conditions identified by the researchers.

Design outcomes

Primary

MeasureTime frame
image display;Image noise;Motion artifact;—

Countries

China

Contacts

Public ContactYuan Xuchun

Fuwai Hospital Chinese Academy of Medical Sciences,Shen Zhen

yxchmail@aliyun.com+86 13602582571

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026